FREMONT, Calif., Dec. 17 /PRNewswire/ -- ViOptix, a Fremont, CA-based developer and manufacturer of non-invasive local tissue oxygen measuring devices with applications inplastic, reconstructive and vascular surgery, announced this week that it has appointed Debra Young, Vice-President and Chief Financial Officer.
Young joins ViOptix from Philips Medical Systems where she was Chief Financial Officer of the Nuclear Medicine Division. Prior to Philips, she held finance management positions in Somnus Medical Technologies, Silicon Valley Group and Applied Materials and was Audit Manager with Ernst & Young LLP.
In making the announcement, Mohamed Elmandjra, ViOptix President and CEO, commented, "Debra brings 18 years of rich experience in small and large companies and will be a tremendous asset to the company as we drive business growth."
Young holds an NDA from New Zealand and is a Certified Chartered Accountant.
About ViOptix, Inc.
Backed by venture capital, ViOptix, Inc. (http://www.vioptix.com/) has developed and patented a revolutionary new technology (Optical Diffusion Imaging and Spectroscopy or "ODIS"), which enables non-invasive, direct, real-time estimation of local tissue oxygen saturation (StO2) on a very cost-effective basis. Its technology will be used in diagnostic and monitoring equipment that has a wide variety of potential clinical applications including plastic, reconstructive and orthopaedic surgery as well as peripheral vascular disease.
ViOptix is located in Fremont, California, in the Silicon Valley area. Its private Canadian venture company, ViOptix Canada, is headquartered in Toronto, Ontario, Canada.
ViOptix, Inc.CONTACT: Susie Faries, Senior Director of Marketing of ViOptix, Inc.,+1-510-226-5860, ext. 217, or fariess@vioptix.com
Web site: http://www.vioptix.com/
